Literature DB >> 28608416

Increased prevalence of allergic asthma from 1996 to 2006 and further to 2016-results from three population surveys.

Helena Backman1, Petri Räisänen1, Linnea Hedman1,2, Caroline Stridsman2, Martin Andersson1, Anne Lindberg3, Bo Lundbäck4, Eva Rönmark1.   

Abstract

BACKGROUND: During the latter half of the 20th century, the prevalence of asthma and many other allergic diseases has increased. Information on asthma prevalence trends among adults after 2010, especially regarding studies separating allergic asthma from non-allergic asthma, is lacking.
OBJECTIVE: The aim was to estimate prevalence trends of current asthma among adults, both allergic and non-allergic, from 1996 to 2016.
METHODS: Three cross-sectional samples from the same area of Sweden, 20-69 years, participated in surveys with the same questionnaire in 1996 (n=7104 participants, 85% response rate), 2006 (n=6165, 77%) and 2016 (n=5466, 53%), respectively. Allergic rhino-conjunctivitis (ARC) was used as a marker for allergic sensitization to define allergic asthma.
RESULTS: The prevalence of current asthma increased from 8.4% (95% CI: 7.8-9.0) in 1996 to 9.9% (95% CI: 9.2-10.6) in 2006 and 10.9% (95% CI: 10.1-11.7) in 2016 (P<.001). Allergic asthma increased from 5.0% (95% CI: 4.5-5.5) in 1996 to 6.0% (95% CI: 5.4-6.6) in 2006 and further to 7.3% (95% CI: 6.6-8.0) in 2016 (P<.001), while the prevalence of non-allergic asthma remained stable around 3.4%-3.8%. The increase in current asthma was most pronounced among women and among the middle-aged. Physician-diagnosed asthma, asthma medication use and ARC also increased significantly, while the prevalence of symptoms common in asthma such as wheeze and attacks of shortness of breath decreased slightly or was stable. The prevalence of current smoking decreased from 27.4% in 1996 to 12.3% in 2016. CONCLUSIONS AND CLINICAL RELEVANCE: The prevalence of allergic asthma increased from 1996 to 2006 and further to 2016, while the prevalence of non-allergic asthma remained on a stable prevalence level. The prevalence of symptoms common in asthma decreased slightly or was stable despite a substantial decrease in the prevalence of current smoking. Clinicians should be aware that the previously observed increase in prevalence of allergic asthma is still ongoing.
© 2017 The Authors. Clinical & Experimental Allergy published by John Wiley & Sons Ltd.

Entities:  

Keywords:  asthma; epidemiology; rhinitis

Mesh:

Year:  2017        PMID: 28608416     DOI: 10.1111/cea.12963

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  41 in total

1.  Burden and prevalence of prognostic factors for severe COVID-19 in Sweden.

Authors:  Katalin Gémes; Mats Talbäck; Karin Modig; Anders Ahlbom; Anita Berglund; Maria Feychting; Anthony A Matthews
Journal:  Eur J Epidemiol       Date:  2020-05-18       Impact factor: 8.082

2.  Design of peptides with high affinity binding to a monoclonal antibody as a basis for immunotherapy.

Authors:  Surendra S Negi; Randall M Goldblum; Werner Braun; Terumi Midoro-Horiuti
Journal:  Peptides       Date:  2021-08-16       Impact factor: 3.750

Review 3.  Modified Allergens for Immunotherapy.

Authors:  Pattraporn Satitsuksanoa; Anna Głobińska; Kirstin Jansen; Willem van de Veen; Mübeccel Akdis
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-16       Impact factor: 4.806

4.  Use of the Pediatric Asthma Risk Score to predict allergic and nonallergic asthma.

Authors:  Eric Schauberger; Jocelyn M Biagini Myers; Hua He; Lisa J Martin; S Hasan Arshad; Ramesh Kurukulaaratchy; Gurjit K Khurana Hershey
Journal:  Ann Allergy Asthma Immunol       Date:  2020-03-20       Impact factor: 6.347

5.  Genetic Polymorphism of MBL 2 in Patients with Allergic Bronchial Asthma.

Authors:  Simona Borta; Romana Popetiu; Imola Donath-Miklos; Maria Puschita
Journal:  Maedica (Buchar)       Date:  2019-09

6.  Pilot-Scale Study Of Human Plasma Proteomics Identifies ApoE And IL33 As Markers In Atopic Asthma.

Authors:  Moumita Bhowmik; Sreyashi Majumdar; Angira Dasgupta; Swati Gupta Bhattacharya; Sudipto Saha
Journal:  J Asthma Allergy       Date:  2019-09-20

Review 7.  Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?

Authors:  Cezmi A Akdis
Journal:  Nat Rev Immunol       Date:  2021-04-12       Impact factor: 53.106

8.  Asthma prevalence and associated factors among lebanese adults: the first national survey.

Authors:  Zeina Akiki; Danielle Saadeh; Rita Farah; Souheil Hallit; Hala Sacre; Hassan Hosseini; Pascale Salameh
Journal:  BMC Pulm Med       Date:  2021-05-13       Impact factor: 3.317

9.  Bronchodilator response and lung function decline: Associations with exhaled nitric oxide with regard to sex and smoking status.

Authors:  Elisabet Nerpin; Diogenes Seraphim Ferreira; Joost Weyler; Vivi Schlunnsen; Rain Jogi; Chantal Raherison Semjen; Thorainn Gislasson; Pascal Demoly; Joachim Heinrich; Dennis Nowak; Angelo Corsico; Simone Accordini; Alessandro Marcon; Giulia Squillacioti; Mario Olivieri; Rune Nielsen; Ane Johannessen; Francisco Gómez Real; Judith Garcia-Aymerich; Isabel Urrutia; Antonio Pereira-Vega; Jose Antonio Gullón; Anna-Carin Olin; Bertil Forsberg; Össur Ingi Emilsson; Isabelle Pin; Deborah Jarvis; Christer Janson; Andrei Malinovschi
Journal:  World Allergy Organ J       Date:  2021-05-18       Impact factor: 4.084

10.  High but stable incidence of adult-onset asthma in northern Sweden over the last decades.

Authors:  Petri Räisänen; Helena Backman; Linnea Hedman; Martin Andersson; Caroline Stridsman; Hannu Kankaanranta; Pinja Ilmarinen; Heidi Andersen; Päivi Piirilä; Anne Lindberg; Bo Lundbäck; Eva Rönmark
Journal:  ERJ Open Res       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.